These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 17199728

  • 1. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
    Räkel A, Renier G, Roussin A, Buithieu J, Mamputu JC, Serri O.
    Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE, Belch JJ.
    Ter Arkh; 2001 Jan; 73(4):27-31. PubMed ID: 11494442
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients.
    De Mattia G, Laurenti O, Fava D.
    J Diabetes Complications; 2003 Jan; 17(2 Suppl):30-5. PubMed ID: 12623166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI, Morozova TP, Chachiashvili MV.
    Sov Med; 1987 Jan; (7):21-2. PubMed ID: 3317910
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.
    Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
    [Abstract] [Full Text] [Related]

  • 17. Effects of gliclazide beyond metabolic control.
    Ceriello A.
    Metabolism; 2006 May; 55(5 Suppl 1):S10-5. PubMed ID: 16631804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L, Nelson SE.
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.